Suppr超能文献

基于结肠黏膜转录组学方法研究精油对 DSS 诱导的小鼠溃疡性结肠炎的保护机制。

Protective mechanisms of essential oil on DSS-induced ulcerative colitis in mice based on a colonic mucosal transcriptomic approach.

机构信息

State Key Laboratory of Southwestern Chinese Medicine Resources, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, 611130, China.

Oncology Teaching and Research Department, Hospital of Chengdu University of Traditional of Chinese Medicine, Chengdu 610072, China.

出版信息

Food Funct. 2022 Sep 22;13(18):9324-9339. doi: 10.1039/d1fo04323d.

Abstract

The ameliorative effects on ulcerative colitis (UC) as well as the related mechanisms of the essential oil derived from the edible herb Maxim (ZBEO) have been demonstrated herein. Based on GC-MS analysis, 45 volatile compounds in ZBEO were determined for its quality control. studies showed that after pretreatment with ZBEO, the disordered expression levels of pro-inflammatory cytokines (TNF-α, IL-6, and IL-1β) and an anti-inflammatory cytokine (IL-10) on colon epithelial NCM460 cells induced by lipopolysaccharide (LPS) could be reversed. Additionally, oral administration of ZBEO significantly alleviated colitis in dextran sulfate sodium (DSS)-induced UC mice, including body weight loss, colon length shortening, disease activity index and colonic pathological damage. Furthermore, to uncover the anti-UC mechanisms of ZBEO, analysis of transcriptomes by next-generation sequencing technology was performed to explore the RNA genetic variation on colon tissues. Based on GO analysis and KEGG pathway analysis, a series of genetic pathways involved in the protective role of ZBEO against UC were determined. As a result, ZBEO treatment could decrease the expression of VCAM-1, TLR8, IL-1β and IL-11 mRNA as verified by qRT-PCR, which are involved in these potential genetic pathways. In conclusion, ZBEO administration would be a medicinal or dietary supplementation strategy for ulcerative colitis treatment.

摘要

本文研究了食用草药大蓟(ZBEO)精油对溃疡性结肠炎(UC)的改善作用及其相关机制。通过 GC-MS 分析,确定了 ZBEO 中 45 种挥发性化合物,用于其质量控制。研究表明,ZBEO 预处理后,可逆转脂多糖(LPS)诱导的结肠上皮 NCM460 细胞中促炎细胞因子(TNF-α、IL-6 和 IL-1β)和抗炎细胞因子(IL-10)的紊乱表达。此外,口服 ZBEO 可显著减轻葡聚糖硫酸钠(DSS)诱导的 UC 小鼠的结肠炎,包括体重减轻、结肠缩短、疾病活动指数和结肠病理损伤。此外,为了揭示 ZBEO 抗 UC 的机制,通过下一代测序技术对转录组进行了分析,以探讨结肠组织中 RNA 遗传变异。基于 GO 分析和 KEGG 途径分析,确定了一系列与 ZBEO 对 UC 的保护作用相关的遗传途径。结果表明,qRT-PCR 验证,ZBEO 治疗可降低 VCAM-1、TLR8、IL-1β和 IL-11 mRNA 的表达,这些基因参与了这些潜在的遗传途径。总之,ZBEO 的给药可能是溃疡性结肠炎治疗的一种药物或饮食补充策略。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验